Home > Press > QBIC connects with China by signing a framework partnership agreement
The Quebec Biotechnology Innovation Centre (QBIC) today signed a framework agreement with BioBay - Suzhou Industrial Park, a science and industrial park in Shanghai. This agreement will allow both organizations to develop exchange projects and implement bio-incubator operating practices. Moreover, their respective companies will receive invaluable guidance in their international development efforts.
QBIC connects with China by signing a framework partnership agreement
LAVAL, Canada and China | Posted on November 1st, 2007
In the past few years, the life sciences sector has enjoyed spectacular
growth in a number of Asian countries where many companies and researchers
have moved. According to QBIC Board Chairman Dr. Jacques Gagné, "it has become
very important even for start-ups to quickly gain access to international
scientific and commercial networks."
During its third visit to QBIC, which took place this past summer, Suzhou
Industrial Park had stated it planned to develop more concrete ties with the
organization, notably within the framework of BioBay, a major nine-phase
project that will ultimately provide Suzhou Industrial Park with substantial
life science infrastructures. Phase 1 was launched in June and includes a
business incubator similar to QBIC.
Suzhou Industrial Park recently received approval from the Ministry of
Science and Technology for its NanoBay project, which will become the largest
nanotechnology cluster in China.
About Quebec Biotechnology Innovation Centre (QBIC)
About the Quebec Biotechnology Innovation Centre (QBIC)
The Quebec Biotechnology Innovation Centre specializes in life sciences
and is located in the heart of the City of Biotechnology and Human Health in
Laval. Internationally renowned, QBIC won the Randall M. Whaley Incubator of
the Year Award in 2002, the highest international honour bestowed on a
business incubator in all categories. ( http://www.cqib.org )
About Suzhou Industrial Park (SIP)
SIP was set up in 1994 as a joint project between the governments of the
People's Republic of China and Singapore. By early 2007, SIP had already
attracted over 2,714 foreign investments for a total value of more than
$27 billion. Over 120,000 people work in the park, which is about as large as
the City of Laval and is home to 66 Fortune 500 companies. ( http://www.biobay.com.cn )
For more information, please click here
Normand de Montigny
Copyright © CNW Group Ltd.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Advantest to Exhibit at SEMICON Korea in Seoul, South Korea February 4-6 Showcasing Broad Portfolio of Semiconductor Products, Technologies and Solutions January 29th, 2015
Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015
2015 Nanonics Image Contest January 29th, 2015
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015
The Original Frameless Shower Doors Installs DFI's FuseCube™ to Offer Hydrophobic Protective Coating as a Standard Feature: First DFI FuseCube™ Installed on the East Coast to Enable Key Differentiator for the Original Frameless Shower Doors January 29th, 2015
Entanglement on a chip: Breakthrough promises secure communications and faster computers January 27th, 2015
Smart keyboard cleans and powers itself -- and can tell who you are January 21st, 2015
DNA 'glue' could someday be used to build tissues, organs January 14th, 2015
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
Carbon nanoballs can greatly contribute to sustainable energy supply January 27th, 2015
Visualizing interacting electrons in a molecule: Scientists at Aalto University and the University of Zurich have succeeded in directly imaging how electrons interact within a single molecule January 26th, 2015
Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015